Biospherix

What Biospherix does

BioSpherix, founded in 2001 and headquartered in Parish, United States, is a privately held manufacturer of laboratory equipment designed to control and maintain in-vitro and in-vivo environments. The company employs between 101 and 250 people and sells into the life sciences industry - principally biotechnology and pharmaceutical customers engaged in cell therapy, gene therapy, biologics development, and regenerative medicine research.

Its core technology is automated cell culture systems engineered for life sciences research and cell therapy production. The product line addresses three functional problems in advanced therapeutic manufacturing: reproducibility in cell culture, contamination risk in open processes, and scalable production for clinical and commercial cell therapy. The value proposition is positioned around closed-system processing, which supports regulatory compliance and process repeatability for biologics and advanced therapeutic developers.

The business model is a direct-to-customer equipment sale into life sciences labs and cell therapy manufacturers; no pricing, distribution channels, or marketing channels are publicly disclosed in the source data. Revenue, funding history, ownership structure, and management team composition are also undisclosed, and the company's website returned only a verification page at the time of source capture, limiting visibility into product breadth, commercial terms, and recent corporate activity beyond the CEO's 2025 participation in a Cornell Center for Advanced Technology industry panel.

Name

Biospherix

Website

https://biospherix.com

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

11–50 employees

Short description

BioSpherix manufactures automated cell culture systems that control in-vitro and in-vivo laboratory environments, serving biotechnology and pharmaceutical customers developing cell therapies, gene therapies, and biologics.

Ownership category

akta.pro rank

Headquarters

HQ city

Parish

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Technology or R&D, Supply Chain, Marketing or Sales

Core offering

Biospherix manufactures specialized laboratory equipment designed to control and maintain in-vitro and in-vivo environments for life sciences research and clinical applications. Its core product line consists of automated, closed cell culture systems aimed at improving reproducibility, reducing contamination risk, and enabling scalable production for cell therapy, gene therapy, biologics, and regenerative medicine programs.

Differentiator

Problem solved

Functional benefit

Products and services

• Automated cell culture systems Automated and closed cell culture equipment designed to control and maintain in-vitro and in-vivo environments for life sciences research, cell therapy production, biologics manufacturing, and regenerative medicine development. Targeted at biotechnology and pharmaceutical organizations that require reproducibility, contamination control, and scalable production for advanced therapeutic applications.

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Cornell Center for Advanced Technology (CAT) in Life Science EnterprisecoreStrategic or Co-development PartnerBiospherix CEO participated in panel discussions at Cornell CAT's daylong event promoting academic-industry collaboration in life sciences. The event brought together faculty, researchers, entrepreneurs, and industry partners from across New York State to discuss commercialization of discoveries. Cornell maintains over 500 active industry partnerships and has launched 20 technology-based companies.

Scale indicators3 records

Recent moves2 records

Expansion highlights2 records

Broad incumbents

• Sartorius: Sartorius is a leading manufacturer of bioprocessing equipment, including cell culture bioreactors, single-use systems, and process control technologies. It competes with Biospherix in automated and closed cell culture systems, particularly for cell therapy and biologics production, with a much broader global footprint and product range.
• Lonza: Lonza is a leading contract development and manufacturing organization (CDMO) that also produces cell and gene therapy manufacturing equipment and consumables. Its cell therapy services and bioprocessing products overlap with Biospherix's focus on cell therapy and biologics manufacturing, though at significantly greater scale.
• Cytiva: A global leader in bioprocessing equipment and consumables, Cytiva (formerly GE Healthcare Life Sciences) offers cell culture systems, bioreactors, and single-use solutions for cell therapy and biologics manufacturing. It directly overlaps with Biospherix in cell culture and bioprocessing equipment but at much greater scale with a comprehensive portfolio.
• Thermo Fisher Scientific: Thermo Fisher provides cell culture media, equipment, and bioproduction services through its Life Sciences Solutions and Pharma Services segments. Its cell therapy manufacturing offerings and bioproduction equipment overlap with Biospherix's cell culture focus, but at significantly greater scale with an integrated solutions portfolio.
• Eppendorf: Eppendorf manufactures a wide range of laboratory equipment, including bioreactors and cell culture systems (e.g., BioFlo and DASbox). It competes with Biospherix in laboratory-scale cell culture equipment but serves a broader customer base across research and bioprocessing applications.

Direct peers

• Wilson Wolf Manufacturing: Wilson Wolf is the developer of G-Rex bioreactors, a specialized cell culture vessel system widely used in cell therapy manufacturing. As a focused specialist in cell expansion technology for cell and gene therapy, it is one of the closest direct competitors to Biospherix in closed-system cell culture equipment.
• Terumo Blood and Cell Technologies: Terumo BCT provides automated cell processing and cell expansion systems used in cell therapy manufacturing and regenerative medicine. Its focus on closed, automated cell processing for therapeutic applications directly overlaps with Biospherix's cell culture and closed-system manufacturing offerings.
• PBS Biotech: PBS Biotech manufactures single-use bioreactors designed for cell therapy and bioprocessing applications, including the Vertical-Wheel technology. Its focus on closed, single-use cell culture systems for advanced therapeutics makes it a direct peer to Biospherix in specialized bioreactor equipment.
• Miltenyi Biotec: Miltenyi Biotec specializes in cell processing, cell culture, and cell therapy manufacturing solutions, including automated closed systems. Its CliniMACS and MACS technologies serve the same cell therapy and regenerative medicine market as Biospherix, making it a direct competitor in automated cell processing equipment.

Emerging players

• CellGenix: CellGenix produces GMP-grade cell culture media, cytokines, and reagents for cell therapy manufacturing. While primarily a consumables/reagents company, it serves the same cell therapy and regenerative medicine customer base as Biospherix, making it an adjacent peer in the cell therapy manufacturing supply chain.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat2 records

Key risks4 records

Key highlights4 records

Customer concentration

• Xx.com/BioSpherix
• Facebookfacebook.com/BiospherixLtd

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biospherix